| Title : Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet - Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| Author(s) : Halimi S , Schweizer A , Minic B , Foley J , Dejager S |
| Ref : Vasc Health Risk Manag , 4 :481 , 2008 |
| Abstract : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| ESTHER : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| PubMedSearch : Halimi_2008_Vasc.Health.Risk.Manag_4_481 |
| PubMedID: 18827867 |
| Title : The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion - El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| Author(s) : El-Ouaghlidi A , Rehring E , Holst JJ , Schweizer A , Foley J , Holmes D , Nauck MA |
| Ref : J Clinical Endocrinology Metab , 92 :4165 , 2007 |
| Abstract : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| ESTHER : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedSearch : El-Ouaghlidi_2007_J.Clin.Endocrinol.Metab_92_4165 |
| PubMedID: 17698900 |
| Title : Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response - Ristic_2005_Diabetes.Obes.Metab_7_692 |
| Author(s) : Ristic S , Byiers S , Foley J , Holmes D |
| Ref : Diabetes Obes Metab , 7 :692 , 2005 |
| Abstract : Ristic_2005_Diabetes.Obes.Metab_7_692 |
| ESTHER : Ristic_2005_Diabetes.Obes.Metab_7_692 |
| PubMedSearch : Ristic_2005_Diabetes.Obes.Metab_7_692 |
| PubMedID: 16219012 |